Education and Training

Radiation Therapy Residency

Medical Students

Medical Physics Residency

Supporting Patient Decisions About UE Surgery in Cervical SCI

The goal of this study is to collect and describe patient and caregiver reported outcomes regarding surgical and non-surgical treatment for improving hand and arm function in the setting of cervical spinal cord injury. Eligible study participants will be recruited across the 4 sites and the investigators plan to recruit the following groups and numbers of participants:

1. Nerve or tendon transfer recipients: people who have elected to undergo nerve (N=10) or tendon (N=10) transfer surgery to restore some hand and arm function as part of their standard clinical care and their caregiver (N=20)

2. Non-surgical control group: people with cervical SCI (N=20) and their caregiver (N=20)

Stanford is currently not accepting patients for this trial.

Stanford Investigator(s):

Intervention(s):

  • other: Semi-structured interview
  • other: Spinal Cord Independence Measure (SCIM-SR)
  • other: SF-36

Eligibility


CERVICAL SPINAL CORD INJURY PARTICIPANTS

Inclusion criteria:

   - Adult subjects (≥18 years and < 80 years) with cervical level SCI ASIA A, B or C
   (minimum 6 months and maximum 20 years post-injury).

Exclusion criteria:

   - Patient who chooses simultaneous tendon and nerve transfer procedure (this would
   preclude separation of the influence of one surgery compared to the other)

   - Patient has ASIA D status (these patients may have progressive return of functionally
   useful motor function below the level of the SCI and would not routinely be offered
   acute surgical intervention and their experiences are less-relevant to the target
   patient population).

CAREGIVER PARTICIPANTS

Inclusion criteria:

   - At least 18 years of age

   - Able to answer questions about the primary participant's experiences with cervical
   spinal cord injury

Exclusion criteria:

   - The caregiver/spouse declines to participate in the study. Note: Caregiver
   participation is preferred, but not required, for SCI participant enrollment.

Ages Eligible for Study

18 Years - 80 Years

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Catherine Curtin, MD
650-725-7181
Not Recruiting